Real-time enrollment status for this malignant germ cell tumor clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 4:28 PM UTC
| NCT Number | NCT07705035 |
| Recruiting Status | Recruiting |
| Condition | Malignant Germ Cell Tumor |
| Phase | PHASE1 |
| Target Enrollment | 210 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Duboce Biopharmaceuticals, Inc. |
| Last Updated on CT.gov | July 15, 2026 (5 days ago) |
As of July 20, 2026: Clinical trial NCT07705035 is currently recruiting participants. This phase1 study for malignant germ cell tumor is actively seeking new participants at 3 locations across the United States. The study is sponsored by Duboce Biopharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07705035 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07705035 was last updated 5 days ago (July 15, 2026). HelloStudys verifies this status automatically.